CHARLOTTESVILLE, Virginia, December 6, 2016—Solidifying their intellectual-property distinction, RIVANNA announces three Notices of Allowance for the Accuro ultrasound-based guidance system and the Accuro Locator Needle Guide. Applications 13/574,738 and 13/922,324 received Notices of Allowance from the United States Patent and Trademark Office (USPTO) while application 2014-508505 received a Notice of Allowance from Japan. These Notices of Allowance confirm the examinations of the patent applications, likely resulting in the expedient issuing of a patent. RIVANNA has additional patent applications in review by patent offices around the globe.
“These initial Notices of Allowance are more great news for our growing team,” says RIVANNA Chairman and CEO Will Mauldin. “It reinforces the exclusivity of Accuro’s technology. Following these issuances, we anticipate accelerated notifications worldwide.”
Accuro’s proprietary technology enables you to see what other ultrasound systems cannot see. Its state-of-the-art image guidance includes BoneEnhance™, which is designed for superior ultrasound visualization of bone, and SpineNav3D™, which guides you with automatic identification of the spinal midline and epidural space.
“Accuro was engineered with ease-of-use in mind. Its automated navigation benefits the physician with easy-to-interpret, precise identification of epidural location and depth,” says RIVANNA Chairman and CEO Will Mauldin. “Our goal is to improve efficiency which will enhance patient satisfaction, and the overall quality of medical care.”
ABOUT ACCURO
Accuro, by RIVANNA, is the world’s first ultrasound-based system specifically designed to help anesthesia providers effortlessly apply spinal and epidural anesthesia. Accuro’s revolutionary image-guidance platform features SpineNav3D™, which automates measurements of the spinal midline, epidural depth and trajectory, and BoneEnhance®, a technology innovation designed to visualize bone landmarks, making it easier and faster (compared to conventional ultrasound) to interpret the underlying image. Accuro supports a sterile environment for optimal patient safety. For anesthesia providers, certainty can be effortless with Accuro.
ABOUT RIVANNA MEDICAL
Rivanna Medical, located in Charlottesville, Virginia, is the innovative medical-device company that imagined, engineered and commercialized Accuro. Addressing the last frontier of image guidance in anesthesia, Rivanna Medical’s revolutionary application of automated 3D-navigation technology to ultrasound imaging of the spine gives anesthesia providers an intuitive extension of their hands to precisely administer epidural and spinal anesthesia. This proprietary imaging device is FDA 510(k)-cleared for spinal-anesthesia guidance and a variety of additional imaging applications. For information about the easy-to-use Accuro or the medical-device company RIVANNA, please visit rivannamedical.com.
Copyright © by Rivanna Medical, LLC. All rights reserved. RIVANNA™, Accuro™, BoneEnhance™, and SpineNav3D™ are trademarks of Rivanna Medical, LLC.
The Accuro™ ultrasound system is covered by U.S. and foreign patents pending